Tender detail
Aflibercept medicinal products for the procurement period 1 January–31 December 2027
Summary
The procurement concerns aflibercept medicinal products in ATC group S01LA05 for intravitreal injection in adults in Finland. The products must have marketing authorisation, be marketed in Finland and be available from 1 January 2027. The tender deadline is 10 September 2026. Precise exclusion, qualification and compliance requirements were not included in the machine-readable notice and must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.